Detalhe da pesquisa
1.
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
N Engl J Med
; 386(10): 951-963, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045226
2.
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers.
Clin Infect Dis
; 76(3): e533-e536, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723273
3.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Lancet Oncol
; 22(12): 1681-1691, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767759
4.
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Nat Commun
; 15(1): 4224, 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762522
5.
GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.
J Infect Dis
; 205(3): 466-73, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22147791
6.
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice.
Pharmaceutics
; 15(2)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36839998
7.
Effect of DMARDs on the immunogenicity of vaccines.
Nat Rev Rheumatol
; 19(9): 560-575, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37438402
8.
Development of an inhalable antiviral powder formulation against respiratory syncytial virus.
J Control Release
; 357: 264-273, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015293
9.
Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice.
Pharmaceutics
; 15(7)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37514034
10.
Efficient fabrication of thermo-stable dissolving microneedle arrays for intradermal delivery of influenza whole inactivated virus vaccine.
Biomater Sci
; 11(20): 6790-6800, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622228
11.
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.
iScience
; 26(1): 105753, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507223
12.
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Lancet Infect Dis
; 23(8): 901-913, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088096
13.
[A preview of COVID-19 vaccination and treatment]. / Een vooruitblik op covid-19-vaccinatie en -behandeling.
Ned Tijdschr Geneeskd
; 1662022 05 12.
Artigo
em Holandês
| MEDLINE | ID: mdl-36036707
14.
Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro.
Pharmaceuticals (Basel)
; 15(7)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35890185
15.
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
Front Immunol
; 13: 1067749, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524126
16.
The COVID HOME study research protocol: Prospective cohort study of non-hospitalised COVID-19 patients.
PLoS One
; 17(11): e0273599, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327223
17.
Advances in the development of entry inhibitors for sialic-acid-targeting viruses.
Drug Discov Today
; 26(1): 122-137, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099021
18.
[SARS coronavirus-2 vaccines: options and state-of-the-art]. / Vaccins tegen SARS-CoV-2.
Ned Tijdschr Geneeskd
; 1642020 09 03.
Artigo
em Holandês
| MEDLINE | ID: mdl-33030329
19.
Development of an Orodispersible Film Containing Stabilized Influenza Vaccine.
Pharmaceutics
; 12(3)2020 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32182676
20.
A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro.
Vaccines (Basel)
; 7(4)2019 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766202